Skip to main content

Federal Funding Opportunities

Browse federal grant opportunities from Grants.gov

Clear
HHS-NIH11 Posted
Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not …

HHS-NIH11

The purpose of this Notice of Funding Opportunity (NOFO) is to provide continuing support for specific pathogen-free (SPF) macaque colonies previously funded under the auspices of PAR-21-089 and PAR-…

Funding Range
Not specified
Total Funding
N/A
Closes: Sep 25, 2026 184 days left
View Details
HHS-NIH11 Posted
International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required)

HHS-NIH11

The purpose of the International Research Scientist Development Award (IRSDA) is to provide support and protected time (three to five years) to advanced postdoctoral U.S. research scientists and rece…

Funding Range
Not specified
Total Funding
N/A
Closes: Mar 09, 2026 Deadline passed
View Details
HHS-NIH11 Posted
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

HHS-NIH11

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the po…

Funding Range
Up to $1,500,000.00
Total Funding
N/A
Closes: Mar 05, 2027 345 days left
View Details
DOE-NNSA Posted
MINORITY SERVING INSTITUTIONS PARTNERSHIP PROGRAM (MSIPP) CONSORTIA GRANT PROGRAM (CGP)

DOE-NNSA

The intent of this funding opportunity is to award new or renewal grant awards to consortia consisting of Minority Serving Institution (MSIs) and Tribal Colleges and Universities (TCUs) to with a foc…

Funding Range
$500,000.00 – $5,000,000.00
Total Funding
$25,000,000.00
Closes: Jun 15, 2026 82 days left
View Details
HHS-NIH11 Posted
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research …

HHS-NIH11

This funding opportunity announcement (FOA) encourages applications for institutional research career development (K12) programs that propose to support intensive supervised research training and car…

Funding Range
Up to $750,000.00
Total Funding
N/A
Closes: Nov 13, 2026 233 days left
View Details
HHS-AHRQ Posted
Systems-Based Approaches to Improve Patient Safety by Improving Healthcare Worker Safety and Well-Being (R01 Clinical …

HHS-AHRQ

The purpose of this Notice of Funding Opportunity (NOFO) is to advance system-level approaches to improve patient safety by improving healthcare worker safety and well-being. Patient safety cannot be…

Funding Range
Up to $500,000.00
Total Funding
N/A
Closes: Mar 25, 2026 0 days left
View Details
HHS-NIH11 Posted
Omics Phenotypes Related to Down Syndrome for the INCLUDE Project (X01 Clinical Trial Not Allowed)

HHS-NIH11

This Notice of Funding Opportunity (NOFO) invites applications to usethe NIH INCLUDE Project (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) to access resou…

Funding Range
Not specified
Total Funding
N/A
Closes: Mar 13, 2026 Deadline passed
View Details
HHS-FDA Forecasted
Minor Use Minor Species Development of Drugs (R01)

HHS-FDA

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from instit…

Funding Range
$250,000.00 – $250,000.00
Total Funding
N/A
Close date: N/A
View Details
HHS-FDA Forecasted
Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial …

HHS-FDA

FDA announces the availability of fiscal year (FY) 2024 funds to support one or more projects to 1) collect antimicrobial use data from diverse animal sectors, including domestic livestock, poultry, …

Funding Range
Up to $200,000.00
Total Funding
$600,000.00
Close date: N/A
View Details
HHS-FDA Forecasted
Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

HHS-FDA

The Food and Drug Administration's (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), is announcing this Funding Opportunity Announcement (FOA) for a Cooperative Agreem…

Funding Range
$350,000.00 – $350,000.00
Total Funding
N/A
Close date: N/A
View Details
HHS-FDA Forecasted
Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)

HHS-FDA

The purpose of this funding opportunity is to support the research and development necessary to advance non-invasive (e.g., quantitative tomography-based) technologies, including the development of a…

Funding Range
$250,000.00 – $250,000.00
Total Funding
N/A
Close date: N/A
View Details
HHS-FDA Forecasted
Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial …

HHS-FDA

The objective of this research proposal is to develop physiologically based pharmacokinetic (PBPK) model-based mechanistic in vitro in vivo correlations (IVIVCs) for two major types of long acting in…

Funding Range
Up to $300,000.00
Total Funding
$600,000.00
Close date: N/A
View Details